Regent Pacific Group Limited (0575.HK) Stock

About Regent Pacific Group Limited

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.

Regent Pacific Group Limited (0575.HK) stock trades at $0.92 with a market capitalization of $267.01M. The stock is valued at a price-to-earnings (P/E) ratio of -6.57, price-to-sales of 735.57. Over the past 52 weeks the stock has ranged between $0.57 and $1.22, and currently trades 24.6% below its 52-week high.

On profitability, Regent Pacific Group Limited generates an operating margin of -1813.49%, a net profit margin of 0.00%.

Official website: www.regentpac.com